Synapse

← Journal of Market Access & Health Policy

Papers in Journal of Market Access & Health Policy

Page 2 · newest first

  1. Adopting a Societal Perspective in Health-Economic Evaluation: Analysis of Nine HTA Methodological Guidelines on How to Integrate Societal CostsJournal of Market Access & Health Policy · 2026
  2. Pulmonary Arterial Hypertension and Cancer: Unveiling Parallels in Epidemiology, Clinical Pathways, and Therapeutic StrategiesJournal of Market Access & Health Policy · 2026
  3. Evaluating [18F]-DCFPyL for Detecting Prostate Cancer Recurrence: A Cost–Consequence Comparison with Alternative PET Radiotracers in SpainJournal of Market Access & Health Policy · 2026
  4. Enhancing Patient-Centered Health Technology Assessment: A Modified Delphi Panel for PICOS Scoping in Spinal Muscular AtrophyJournal of Market Access & Health Policy · 2026
  5. Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access AcademyJournal of Market Access & Health Policy · 2026
  6. Overcoming Patient Access Barriers in Complex Conditions: Lessons from Schizophrenia for Broader Healthcare ApplicationsJournal of Market Access & Health Policy · 2025
  7. Knowledge Spillover and Innovation in Healthcare: A Comparative Study of Social Media Interaction Between Medical Technology Companies and Healthcare Professionals in AustriaJournal of Market Access & Health Policy · 2025
  8. The Pharmaceutical Innovativeness Index: Supporting Value-Based Economic Regulation of Innovative MedicinesJournal of Market Access & Health Policy · 2025
  9. Cost-Effectiveness of Electrical Stimulation Therapy in the Treatment of Chronic Wounds: A Systematic Review, Meta-Analysis and Economic AnalysisJournal of Market Access & Health Policy · 2025
  10. Cost-Effectiveness of Electrical Stimulation Therapy in the Treatment of Chronic Wounds: A Systematic Review, Meta-Analysis and Economic AnalysisJournal of Market Access & Health Policy · 2025
  11. Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United KingdomJournal of Market Access & Health Policy · 2025
  12. Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United KingdomJournal of Market Access & Health Policy · 2025
  13. Patient Perspectives on Health Insurance Design: A Mixed-Methods AnalysisJournal of Market Access & Health Policy · 2025
  14. Criterion-Related Validity and Reliability of a Measurement Tool for Medical Doctors’ Work-Related Quality of Life in JapanJournal of Market Access & Health Policy · 2025
  15. Patient Perspectives on Health Insurance Design: A Mixed-Methods AnalysisJournal of Market Access & Health Policy · 2025
  16. The Impact of Copay Accumulators and Maximizers on Treatment Patterns, Adherence, and Costs Among Patients with Major Depressive and Bipolar Disorders Treated with Branded TherapiesJournal of Market Access & Health Policy · 2025
  17. How the Stakeholders’ Perception Contributes to the Pharmaceutical Strategies: A Regional Case Study in Latin AmericaJournal of Market Access & Health Policy · 2025
  18. A Data-Driven Approach for Estimating Type 2 Diabetes-Related Costs in GreeceJournal of Market Access & Health Policy · 2025
  19. EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-MakingJournal of Market Access & Health Policy · 2025
  20. Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move ForwardJournal of Market Access & Health Policy · 2025
  21. Examining State Policies and Administrative Factors as Determinants of Consumer-Reported Unmet Service Needs in Publicly Funded Home- and Community-Based Services in the United StatesJournal of Market Access & Health Policy · 2025
  22. Balancing Costs and Clinical Outcomes: A Cost-Effectiveness Study of PICC Types Across Chinese Healthcare SettingsJournal of Market Access & Health Policy · 2025
  23. Clinical and Economic Evidence Supporting the Value of Fluorescence Imaging of Bacteria in Wound CareJournal of Market Access & Health Policy · 2025
  24. Shaping the Future of HTA in Italy: Insights from the Italian Health Policy ForumJournal of Market Access & Health Policy · 2025
  25. Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European HTA FrameworkJournal of Market Access & Health Policy · 2025
  26. Safe Staffing Standards for Pharmacy Technicians in Hospital SettingsJournal of Market Access & Health Policy · 2025
  27. Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?Journal of Market Access & Health Policy · 2025
  28. Innovative Payment Mechanisms for High-Cost Medical Devices in Latin America: Experience in Designing Outcome Protection Programs in the RegionJournal of Market Access & Health Policy · 2025
  29. Managed Entry Agreements for Pharmaceutical Products in Three Maghreb Countries: Payer and Supplier PerspectivesJournal of Market Access & Health Policy · 2025
  30. European Health Technology Assessment Considerations Related to Gene Therapies in Eyecare: The Neovascular Age-Related Macular Degeneration ExampleJournal of Market Access & Health Policy · 2025
  31. Deploying Experienced Utility in Health Economic Evaluation: A Quantitative StudyJournal of Market Access & Health Policy · 2025
  32. Value-Based Healthcare as a Competitive Strategy—A Multi-Stakeholder Perception Analysis in Portuguese HealthcareJournal of Market Access & Health Policy · 2025
  33. Development of a Work-Related Quality of Life Questionnaire for Medical Doctors (WQMD-9) in Japan: Questionnaire Design and Quantitative SurveyJournal of Market Access & Health Policy · 2025
  34. Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical AssessmentsJournal of Market Access & Health Policy · 2025
  35. Physician Practice Affiliation Drives Site of Care Cost Differentials: An Opportunity to Reduce Healthcare ExpendituresJournal of Market Access & Health Policy · 2025
  36. Preparing for the EU HTA Regulation: Insights from the Dutch PerspectiveJournal of Market Access & Health Policy · 2025
  37. An Estimation of the Economic and Environmental Impact of Inhaler Devices Switch for Non-Clinical Reasons in COPD and Asthma: The Case for SpainJournal of Market Access & Health Policy · 2025
  38. The PICO Puzzle: Can Public Data Predict EU HTA Expectations for All EU Countries?Journal of Market Access & Health Policy · 2025
  39. Opportunities for and Challenges of Conducting Indirect Treatment Comparisons and Meta-Analyses for Vaccines in Post-EU HTA Regulation EraJournal of Market Access & Health Policy · 2025
  40. Exploring Trust in Health Insurers: Insights from Enrollees’ Perceptions and ExperiencesJournal of Market Access & Health Policy · 2025
  41. Health Technology Assessment and Cardiology: A Review of the Present and Future of InnovationJournal of Market Access & Health Policy · 2025
  42. Health and Social Care Integration: Insights from International Implementation CasesJournal of Market Access & Health Policy · 2025
  43. Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the MarkJournal of Market Access & Health Policy · 2025
  44. Enhancing Patient Engagement in HTA: Using Consensus Research to Overcome PICO Scoping Challenges Under the EU HTARJournal of Market Access & Health Policy · 2025
  45. The Art of Bridge Building: A Look at the European-Level Cooperation in HTA (EU-HTA)Journal of Market Access & Health Policy · 2025
  46. Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular CarcinomaJournal of Market Access & Health Policy · 2025
  47. Optimizing Patient Access to Orphan Medicinal Products: Lessons from Central and Eastern EuropeJournal of Market Access & Health Policy · 2025
  48. Streamlining Endoscopy Cleaning: The Impact of a New Detergent on Time and Water UseJournal of Market Access & Health Policy · 2025
  49. Effects of Primary Healthcare Quality and Effectiveness on Hospitalization Indicators in BrazilJournal of Market Access & Health Policy · 2025
  50. Validating the Predictions of a Dynamic Transmission Model Using Real-World Data from a Universal Varicella Vaccination Program in GermanyJournal of Market Access & Health Policy · 2025